Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Falfán Valencia (Mexico, Mexico), I. Buendía-Roldán (Mexico, Mexico), L. Santiago-Ruiz (Mexico, Mexico), G. Pérez-Rubio (Mexico, Mexico), E. Ambrocio-Ortiz (Mexico, Mexico), M. Mejía (Mexico, Mexico), G. Benítez (Mexico, Mexico), M. Montaño (Mexico, Mexico), M. Selman (Mexico, Mexico). HLA class II alleles and haplotypes are associated to the presence autoantibodies and mortality in Hypersensitivity Pneumonitis patients.. 4233

Member's Comments

No comment yet.

Related content which might interest you: Influence of HLA class II  DRB1*/DQB1* alleles in phenotypes of Indian patients of sarcoidois. Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021 HLA class II alleles are associated with development of emphysema in alpha-1-antitrypsin deficiency (AATD) Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008 Frequency of class I and II HLA alleles in patients with lung cancer according to responses of chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 329s Year: 2005 Associations between allergen-specific IgE sensitization and HLA class II alleles in the EGEA cohort Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020 Major histocompatibility complex class II and BTNL2 associations in sarcoidosis Source: Eur Respir J 2013; 42: 550-553 Year: 2013 Imputed classical HLA II alleles, occupational allergen exposure and adult-onset asthma Source: Annual Congress 2012 - Respiratory diseases at at work: epidemiology, inflammation and challenge studies Year: 2012 HLA-class I and II genotyping in sarcoidosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 354s Year: 2006 A haplotype of HLA-class II and BTNL2 associates with the diagnosis of extrinsic allergic alveolitis (EAA) Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008 Is the BTNL2 genotype associated with specific HLA-DRB1 and DRB3/4/5 alleles in Danish sarcoidosis patients? Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Assessment of the association between HLA type and clinically-defined asthma Source: Eur Respir J 2003; 22: Suppl. 45, 192s Year: 2003 HLA genotypes and childhood asthma Source: Eur Respir J 2005; 26: Suppl. 49, 694s Year: 2005 HLA-DRB1 allele distributions in Danish sarcoidosis patients. Increased prevalence of HLA-DRB1*15 Source: Annual Congress 2012 - Sarcoidosis Year: 2012 HLA antigens in Turkish patients with sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 434s Year: 2002 Association between BTNL2 and sarcoidosis evolution is secondary to HLA-DRB1* alleles Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases Year: 2009 Genetic variant in MMP2 increases the risk to develop autoantibodies in patients with Hypersensitivity Pneumonitis Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management Year: 2018 Muscle dysfunction in COPD patients associates with HLA system: risk and protective genotypes Source: Eur Respir J 2005; 26: Suppl. 49, 363s Year: 2005 Analysis of HLA antigens in Turkish sarcoidosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 257s Year: 2003 Major histocompatibility complex and cytokines polymorphisms in hypersensitivity pneumonitis Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease Year: 2006 The genetic markers (HLA system) of steroid-resistance in severe bronchial asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 678s Year: 2006 HLA-DRB1 allele frequencies in Finnish sarcoidosis patients and associations with disease prognosis Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010